Royal Bank Of Canada Sight Sciences, Inc. Transaction History

Royal Bank Of Canada

$422 Billion
Q1 2024

A detailed history of Royal Bank Of Canada transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 8,144 shares of SGHT stock, worth $50,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,144

Previous 12,739 36.07%

Holding current value

$50,411

Previous $65,000 33.85%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.02 - $5.89 $18,471 - $27,064	-4,595 Reduced 36.07%	8,144 $43,000
Q4 2023 Feb 14, 2024	SELL	$1.29 - $5.86 $9,198 - $41,787	-7,131 Reduced 35.89%	12,739 $65,000
Q3 2023 Nov 14, 2023	SELL	$2.88 - $8.8 $77,777 - $237,652	-27,006 Reduced 57.61%	19,870 $66,000
Q2 2023 Aug 14, 2023	BUY	$7.46 - $10.67 $3,633 - $5,196	487 Added 1.05%	46,876 $388,000
Q1 2023 May 15, 2023	SELL	$8.44 - $13.35 $64,616 - $102,207	-7,656 Reduced 14.17%	46,389 $405,000

Q4 2022 Feb 14, 2023	SELL	$5.58 - $13.94 $7,633 - $19,069	-1,368 Reduced 2.47%	54,045 $659,000
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $860 - $1,608	141 Added 0.26%	55,413 $352,000
Q2 2022 Aug 15, 2022	SELL	$6.61 - $11.99 $8,269 - $14,999	-1,251 Reduced 2.21%	55,272 $497,000
Q1 2022 May 16, 2022	BUY	$11.56 - $17.9 $623,384 - $965,275	53,926 Added 2076.47%	56,523 $654,000
Q4 2021 Feb 14, 2022	BUY	$17.36 - $27.36 $3,906 - $6,156	225 Added 9.49%	2,597 $46,000
Q3 2021 Nov 15, 2021	BUY	$22.34 - $39.1 $52,990 - $92,745	2,372 New	2,372 $54,000

Others Institutions Holding SGHT

# of Institutions

Shares Held

21.1M

Call Options Held

33.2K

Put Options Held

27.7K

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $296M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Sight Sciences, Inc. Transaction History